Immtech, Beijing Capital Medical University Form JV To Provide Contract Research Services in China
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Immtech Pharmaceutical has signed a Memorandum of Understanding with Beijing Capital Medical University to establish a joint venture that will provide contract research services in China
You may also be interested in...
SFDA Drafts New Fast Track Procedures For Drug Registration
SHANGHAI - China regulators released a streamlined draft drug approval rule this month that would provide for faster approval of four categories of new drugs. The State Food and Drug Administration finished collecting public comments on the rule Oct. 15
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).